Proteomic Study of Plasma Exosomes in Patients With Diabetic Retinopathy
Status
Conditions
Details and patient eligibility
About
Objective: Explore the biomarkers related to proliferative diabetic retinopathy by analyzing the protein expression profile changes of plasma exosomes in patients with difference phases of diabetic retinopathy, and investigate potential molecular mechanisms and therapeutic targets. Methods: Enrich exosomes from plasma by column extraction method. NTA, WB and TEM were used to characterize the obtained exosomes, and exosome proteinomics was performed by chromatography⁃mass spectrometry. Corhorts: The study was divided into four groups: a healthy control group, a diabetic without diabetic retinopathy group, a non-proliferative diabetic retinopathy group, and a proliferative diabetic retinopathy group, with 6 cases in each group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Healthy volunteers without diabetes/ Senile cataract patients without diabetes；
- Patients with diabetes who are diagnosed without DR, NPDR, and PDR by mydriatic fundus photography (or FFA)；
Exclusion criteria
- Patients with systemic diseases such as cancer, immune diseases, infectious diseases, and blood diseases；
- Patients with cerebral infarction, myocardial infarction and other cardiovascular and cerebrovascular diseases
Trial design
24 participants in 4 patient groups
Trial contacts and locations
Loading...
Central trial contact
Zhen Li, Doctor; Hang Wu, Master
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal